5 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Imaging Study of [89Zr]DFO-YS5 for Cancer DetectionDigestive System Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Nerve Tissue, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, digestive system disorder, hypertrophic pyloric stenosis, neoplasm, nerve sheath neoplasm, nervous system disorder, neuromuscular disease, peripheral nervous system disorder, peripheral nervous system neoplasm, pyloric stenosis, stomach disorder, urinary bladder cancer, urinary bladder disorder, urinary bladder neoplasm, urinary system disorderRecruitingPhase 12026-10-01NCT07664397
Imaging Study of [89Zr]DFO-YS5 for Detecting CD46 Positive Malignancy in Multiple MyelomaBlood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell myeloma, plasma cell neoplasm, vascular disorder, vascular hemostatic diseaseRecruitingPhase 12026-09-16NCT05892393
PET [89Zr]DFO-starPEG in Solid TumorsSoft Tissue Lesion; Solid Carcinoma; Solid TumorRecruitingPhase 12026-06-05NCT06894745
Magnetic Resonance (MR) Imaging With Hyperpolarized Bicarbonate (13C) to Measure Tissue pH in Prostate CancerGenital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorderActive, not recruitingEarly phase 12026-05-04NCT05851365
PET Imaging Study of 89Zr-DFO-YS5 in Men With Prostate CancerGenital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorderActive, not recruitingPhase 12026-03-17NCT05245006